BTA
Click for more information
0.00% 57.0¢ biota holdings limited

So do we have the prospect of GSK pushing a generic relenza into...

  1. jsbuser
    4,443 Posts.
    lightbulb Created with Sketch. 1829
    clock Created with Sketch.
    23/09/12
    08:41
    Post #: 10758422
    So do we have the prospect of GSK pushing a generic relenza into China whilst DS start a push in from Japan with Lani? Or is this not possible licensing wise?
    BTA Price at posting: 70.0¢ Sentiment: LT Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.